Opthea Ltd (OPT)
3.285
-0.06
(-1.65%)
USD |
NASDAQ |
May 01, 16:00
Opthea Revenue (TTM): 0.1171M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.1171M |
June 30, 2023 | 0.1084M |
December 31, 2022 | 0.0977M |
June 30, 2022 | 0.0907M |
December 31, 2021 | -0.0842M |
June 30, 2021 | 0.0686M |
December 31, 2020 | 0.0657M |
June 30, 2020 | 0.0591M |
December 31, 2019 | |
June 30, 2019 | |
December 31, 2018 | |
June 30, 2018 | |
December 31, 2017 | |
June 30, 2017 | |
December 31, 2016 | |
June 30, 2016 | |
December 31, 2015 | |
June 30, 2015 | |
December 31, 2014 | |
June 30, 2014 |
Date | Value |
---|---|
December 31, 2013 | |
June 30, 2013 | |
December 31, 2012 | |
June 30, 2012 | |
December 31, 2011 | |
June 30, 2011 | |
December 31, 2010 | |
June 30, 2010 | |
December 31, 2009 | |
June 30, 2009 | |
December 31, 2008 | |
June 30, 2008 | |
December 31, 2007 | |
June 30, 2007 | 0.0191M |
December 31, 2006 | |
June 30, 2006 | |
December 31, 2005 | 0.0129M |
June 30, 2005 | 0.0133M |
December 31, 2004 | 0.0125M |
June 30, 2004 | 0.0122M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
-0.0842M
Minimum
Dec 2021
0.1171M
Maximum
Dec 2023
0.0654M
Average
0.0796M
Median
Revenue (TTM) Benchmarks
Immutep Ltd | 5.113M |
Kazia Therapeutics Ltd | -- |
Bionomics Ltd | -- |
Alterity Therapeutics Ltd | -0.0416M |
Mesoblast Ltd | 7.501M |